Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leslie Small

Latest From Leslie Small

Rx Oversight Issues at Federal Workers’ Comp Program Endangered Patients, Audit Says

OWCP says that hiring a PBM will address overprescribing and cost concerns, but a consultant who participated in the audit is skeptical.

Government Payers Reimbursement

Even As PBMs Face Reckoning, Formulary Exclusions Rise Again In 2023

Congressional scrutiny aside, ‘the rebate model remains alive and well’ as the big three pharmacy benefit managers exclude around 600 drugs each from their formularies.

Commercial Pricing Debate

AHIP, PhRMA Try to Control Narrative as Heat on PBMs Intensifies

As health insurance lobby launches advertising campaign to defend ‘evidence-based, market-driven tools,’ drug firms point out the connection between insurers and pharmacy benefit managers.

Legislation Pricing Debate
See All
UsernamePublicRestriction

Register